FromAstraZeneca ([email protected])
Subject (46)Final OS results reported for TROPION-Breast01
Preheader (150)Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-
Arial
Text Analysis
Body Words256
Subject Words6
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px868 px
X-Spam Score1.9
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeOvernight
